BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37331287)

  • 1. Same-day repeatability and Between-Sequence reproducibility of Mean ADC in PI-RADS lesions.
    Zhang KS; Neelsen CJO; Wennmann M; Glemser PA; Hielscher T; Weru V; Görtz M; Schütz V; Stenzinger A; Hohenfellner M; Schlemmer HP; Bonekamp D
    Eur J Radiol; 2023 Aug; 165():110898. PubMed ID: 37331287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiparametric Magnetic Resonance Imaging of the Prostate: Repeatability of Volume and Apparent Diffusion Coefficient Quantification.
    Fedorov A; Vangel MG; Tempany CM; Fennessy FM
    Invest Radiol; 2017 Sep; 52(9):538-546. PubMed ID: 28463931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applicability of readout-segmented echoplanar diffusion weighted imaging for prostate MRI.
    Hellms S; Gutberlet M; Peperhove MJ; Pertschy S; Henkenberens C; Peters I; Wacker F; Derlin K
    Medicine (Baltimore); 2019 Jul; 98(29):e16447. PubMed ID: 31335699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent Diffusion Coefficient Values of Prostate Cancer: Comparison of 2D and 3D ROIs.
    Tamada T; Huang C; Ream JM; Taffel M; Taneja SS; Rosenkrantz AB
    AJR Am J Roentgenol; 2018 Jan; 210(1):113-117. PubMed ID: 29045185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment and quantification of sources of variability in breast apparent diffusion coefficient (ADC) measurements at diffusion weighted imaging.
    Giannotti E; Waugh S; Priba L; Davis Z; Crowe E; Vinnicombe S
    Eur J Radiol; 2015 Sep; 84(9):1729-36. PubMed ID: 26078100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-retest repeatability of a deep learning architecture in detecting and segmenting clinically significant prostate cancer on apparent diffusion coefficient (ADC) maps.
    Hiremath A; Shiradkar R; Merisaari H; Prasanna P; Ettala O; Taimen P; Aronen HJ; Boström PJ; Jambor I; Madabhushi A
    Eur Radiol; 2021 Jan; 31(1):379-391. PubMed ID: 32700021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term reproducibility of apparent diffusion coefficient estimated from diffusion-weighted MRI of the prostate.
    Sadinski M; Medved M; Karademir I; Wang S; Peng Y; Jiang Y; Sammet S; Karczmar G; Oto A
    Abdom Imaging; 2015 Oct; 40(7):2523-8. PubMed ID: 25805558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeatability and Reproducibility Assessment of the Apparent Diffusion Coefficient in the Prostate: A Trial of the ECOG-ACRIN Research Group (ACRIN 6701).
    Boss MA; Snyder BS; Kim E; Flamini D; Englander S; Sundaram KM; Gumpeni N; Palmer SL; Choi H; Froemming AT; Persigehl T; Davenport MS; Malyarenko D; Chenevert TL; Rosen MA
    J Magn Reson Imaging; 2022 Sep; 56(3):668-679. PubMed ID: 35143059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motion corrected DWI with integrated T2-mapping for simultaneous estimation of ADC, T2-relaxation and perfusion in prostate cancer.
    Skorpil M; Brynolfsson P; Engström M
    Magn Reson Imaging; 2017 Jun; 39():162-167. PubMed ID: 28286063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeatability of diffusion-weighted MRI of the prostate using whole lesion ADC values, skew and histogram analysis.
    Barrett T; Lawrence EM; Priest AN; Warren AY; Gnanapragasam VJ; Gallagher FA; Sala E
    Eur J Radiol; 2019 Jan; 110():22-29. PubMed ID: 30599864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffusion tensor magnetic resonance imaging of the normal breast: reproducibility of DTI-derived fractional anisotropy and apparent diffusion coefficient at 3.0 T.
    Tagliafico A; Rescinito G; Monetti F; Villa A; Chiesa F; Fisci E; Pace D; Calabrese M
    Radiol Med; 2012 Sep; 117(6):992-1003. PubMed ID: 22580812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeatability and Reproducibility of ADC Measurements and MRI Signal Intensity Measurements of Bone Marrow in Monoclonal Plasma Cell Disorders: A Prospective Bi-institutional Multiscanner, Multiprotocol Study.
    Wennmann M; Thierjung H; Bauer F; Weru V; Hielscher T; Grözinger M; Gnirs R; Sauer S; Goldschmidt H; Weinhold N; Bonekamp D; Schlemmer HP; Weber TF; Delorme S; Rotkopf LT
    Invest Radiol; 2022 Apr; 57(4):272-281. PubMed ID: 34839306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative Apparent Diffusion Coefficient Derived From Diffusion-Weighted Imaging Has the Potential to Avoid Unnecessary MRI-Guided Biopsies of mpMRI-Detected PI-RADS 4 and 5 Lesions.
    Polanec SH; Helbich TH; Bickel H; Wengert GJ; Pinker K; Spick C; Clauser P; Susani M; Shariat S; Baltzer PAT
    Invest Radiol; 2018 Dec; 53(12):736-741. PubMed ID: 29985792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings.
    Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA
    Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Dynamic Contrast-enhanced and Diffusion MRI to PI-RADS for Detecting Clinically Significant Prostate Cancer.
    Tavakoli AA; Hielscher T; Badura P; Görtz M; Kuder TA; Gnirs R; Schwab C; Hohenfellner M; Schlemmer HP; Bonekamp D
    Radiology; 2023 Jan; 306(1):186-199. PubMed ID: 35972360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.
    Sadinski M; Karczmar G; Peng Y; Wang S; Jiang Y; Medved M; Yousuf A; Antic T; Oto A
    AJR Am J Roentgenol; 2016 Sep; 207(3):592-8. PubMed ID: 27352026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeatability and reproducibility of ADC measurements: a prospective multicenter whole-body-MRI study.
    Michoux NF; Ceranka JW; Vandemeulebroucke J; Peeters F; Lu P; Absil J; Triqueneaux P; Liu Y; Collette L; Willekens I; Brussaard C; Debeir O; Hahn S; Raeymaekers H; de Mey J; Metens T; Lecouvet FE
    Eur Radiol; 2021 Jul; 31(7):4514-4527. PubMed ID: 33409773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Test-retest repeatability of ADC in prostate using the multi b-Value VERDICT acquisition.
    Rogers HJ; Singh S; Barnes A; Obuchowski NA; Margolis DJ; Malyarenko DI; Chenevert TL; Shukla-Dave A; Boss MA; Punwani S
    Eur J Radiol; 2023 May; 162():110782. PubMed ID: 37004362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of measurement method on interobserver variability of apparent diffusion coefficient of lesions in prostate MRI.
    Takahashi H; Yoshida K; Kawashima A; Lee NJ; Froemming AT; Adamo DA; Khandelwal A; Bolan CW; Heller MT; Hartman RP; Kim B; Philbrick KA; Carter RE; Mynderse LA; Humphreys MR; Cai JC; Takahashi N
    PLoS One; 2022; 17(5):e0268829. PubMed ID: 35604891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility of Index Lesion Size and Mean Apparent Diffusion Coefficient Values Measured by Prostate Multiparametric MRI: Correlation With Whole-Mount Sectioning of Specimens.
    Diaz de Leon A; Leyendecker JR; Otero-Muinelo S; Grewal H; Xi Y; Francis F; Pedrosa I; Costa DN
    AJR Am J Roentgenol; 2018 Oct; 211(4):783-788. PubMed ID: 30160988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.